Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Report 2016

26 Jan 2017 07:00

RNS Number : 1408V
Ashley House PLC
26 January 2017
 

Ashley House plc

 

Interim Report 2016

 

 

Ashley House plc ("Ashley House" or the "Company"), the health and community care property partner, today announces its interim results for the six months ended 31 October 2016.

 

Highlights

Financial highlights

• Company remains profitable in period.

• Revenue in line with prior year at £10.7m (2015: £10.6m).

• Statutory profit before taxation £0.8m (2015: £0.2m).

• Adjusted profit before taxation £0.2m (2015: £0.4m).

• Net debt £2.4m (2015: £2.6m).

Operating highlights

• Government in consultation on funding for supported housing which is expected to be positively resolved in 2017 but does challenge timing of scheme delivery.

• Award of £11.5m grant funding by the Homes and Communities Agency for future Extra Care schemes with a further £7.5m for other Ashley House schemes via partner.

• Three schemes currently on site (2015: four) being Walton on the Naze (Extra Care) and the Health schemes in Swansea & Wivenhoe.

• Completion of the Harwich Extra Care scheme in December 2016.

• Total forward pipeline, on-site or appointed of 25 schemes with £170.7m of revenue anticipated to be recognised (January 2016: 31 schemes £177.2m).

 

"The Board is pleased that the business remains profitable and, whilst there are still challenges to overcome considers the business is well placed to grow again in the near future."

 Christopher Lyons, Chairman

 

 

Enquiries:

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland 0207 220 1666

(Nominated Adviser and broker to Ashley House plc)

Adrian Hadden

Nick Prowting

 

 

Chairman's Statement

I am pleased to advise that Ashley House has produced a profit before tax for the six months to 31 October 2016 on a turnover in line with the previous year.

In September last year we celebrated the Company's 25 year anniversary and Ashley House continues to expand its product and service offering, applying its skills and experience to the development of health, housing and other community projects.

We continue to wait for full clarity on the Government's proposal to top up housing benefit at a local level to fund supported housing. A consultation process commenced in November jointly commissioned by the Department for Communities & Local Government and the Department for Work & Pensions. In its introduction to the consultation document, the Government reiterates that it is "committed to protecting and boosting the supply of supported housing". We continue to work with our clients, both Councils and Registered Providers, to find solutions to enable at least some of our pipeline schemes to proceed whilst this consultation continues.

This month's announcement by the Homes and Communities Agency of grant funding for the next five years included Ashley House with £11.5m of funding for five of our current schemes. In addition, a Registered Provider partner has been awarded £7.5m for another three of our schemes. The total of £19m of grant funding is a strong indication of the progress the Company has made in this area and of the real opportunity for the business to develop out these schemes once the Government's position on social rents becomes clear.

In each case the grant funding allows the rents to be around 20% lower than they would have been and makes the schemes acceptable to the Local Authority Housing Benefits team. It does not in itself close the gap created by the capping of Housing Benefits to Local Housing Allowance levels, but it should help unlock schemes. Having successfully completed our Extra Care scheme in Harwich last month, we remain on site with the scheme in Walton on the Naze which is due to complete in the coming weeks.

We currently believe that three schemes in our Extra Care pipeline will be able to reach contract before our year end thereby qualifying for revenue recognition, although they all still require Local Authority and partner board final approvals.

Whilst our existing products are much required, the Company will continue to diversify in order to lessen the exposure to the risk of Government making changes that affect the fundamental elements of the business. As mentioned in my last statement in July, we continue to work with a modular construction contractor through a joint venture company in order to increase the speed and efficiency of our existing build programmes. This is enabling us to tap into a new range of products and development opportunities that utilise our skills set and importantly start to move us away from a reliance on Government funded schemes. We hope to be able to announce more concerning this venture in the coming months.

In our Health segment we have commenced construction on two new schemes, a fully integrated GP surgery and family centre complex in Swansea and the redevelopment of an old school building into new surgery premises in Wivenhoe, Essex. The diagnostics and treatment centre in Durham will commence on site in the coming weeks. In addition we continue to support our partners Integrated Pathology Partnerships in their programme of creating new pathology laboratories.

Results

The Company made a profit before taxation of £0.8m in the first half of 2016/17 (2015/16: £0.2m) on revenue of £10.7m (2015/16: £10.6m). The gross margin percentage generated was lower than last year due to the increase in construction income which typically has a lower margin than pre-construction income. The adjusted profit before tax was £0.2m (2015/16: £0.4m). The Company also reached agreement to cancel a significant historic liability with the counterparty, enabling a stronger statutory result to be achieved.

The ongoing Government consultation relating to funding for supported housing means that a further complication is added to the process of contracting on schemes. Subject to the timing risk on some of our schemes as referred to above, the Board expects that the Company will be profitable at the full year.

Net debt

The table below shows net debt of £2.4m at 31 October 2016 (2015: £2.6m). The Company's overdraft facility with Lloyds Bank has recently been extended to £0.75m and renewed until 31 December 2017. As in previous periods all debt at the end of October was secured on amounts incurred on scheme related expenditure. This is largely land purchased for future schemes which stood at £2.8m (2015: £2.8m) as shown in work in progress at the end of October.

In December we announced the refinancing of our loan through a facility with the related party, Invescare Limited. The management of our cash resources continues to be an important aspect of the business.

 

Unaudited

Unaudited

Audited

31 October 2016

31 October 2015

30 April 2016

£000

£000

£000

Cash in bank

(476)

514

23

Loan on Scarborough land

(619)

(797)

(710)

Loan

(1,300)

(2,300)

(1,300)

(2,395)

(2,583)

(1,987)

 

Pipeline

Ashley House's pipeline as at January 2017 is shown in the table below. The value of the stated pipeline has decreased from the previous information published in July 2016 largely due to the recognition of £10m of revenue from the pipeline in the period.

Extra Care

Health

TOTAL

No. of Schemes

Scheme value to come

No. of Schemes

Scheme value to come

No. of Schemes

Scheme value to come

 

On Site

1

£4.1m

2

£3.5m

3

£7.6m

 

Appointed

 

16

 

£145.4m

 

6

 

£17.7m

 

22

 

£163.1m

 

TOTAL

 

17

 

£149.5m

 

8

 

£21.2m

 

25

 

£170.7m

 

Outlook 

We continue to make good progress on schemes in our Extra Care segment although this is not helped by delays caused by the Government's consultation process. Despite this we continue to work with our clients to find solutions to enable schemes to progress to site. We continue to broaden the outlook of the business and once this is achieved and the funding of supported housing is resolved as expected, the Board considers that the opportunities for Ashley House are very strong.

The Board is pleased that the business remains profitable and, whilst there are still challenges to overcome considers the business is well placed to grow again in the near future.

 

Christopher Lyons

25 January 2017

 

 

 

Condensed consolidated interim statement of comprehensive income

 

Unaudited

Unaudited

Audited

6 months to

6 months to

Year to

31 October

31 October

30 April

2016

2015

2016

Note

£000

£000

£000

Revenue

 

10,744

10,626

20,737

Cost of sales

 

(9,059)

(8,343)

(15,944)

Gross profit

 

1,685

2,283

4,793

 

 

 

 

 

Administrative expenses

 

(1,269)

(1,584)

(3,226)

Depreciation and impairment

 

(55)

(185)

(1,514)

Share of results of joint ventures

 

165

(42)

97

Other operating income

 

-

-

581

Exceptional adjustment

 

655

-

-

 

 

 

 

 

Operating profit

 

1,181

472

731

Interest receivable

 

-

-

1

Interest payable

 

(401)

(234)

(491)

Profit before taxation

 

780

238

241

 

 

 

 

 

Profit before taxation

 

780

238

241

Depreciation and impairment

 

55

185

1,514

Taxation included in share of results of joint ventures

 

-

(14)

(14)

Other operating income

 

-

-

(581)

Exceptional adjustment

 

(655)

-

-

Adjusted profit before tax*

 

180

409

1,160

 

 

 

 

 

Tax credit

 

-

-

6

Total comprehensive income for the period

 

780

238

247

 

 

 

 

 

Basic and diluted profit per share

3

1.32p

0.41p

0.42p

Basic and diluted earnings per share on Adjusted PBT*

3

0.31p

0.70p

1.99p

 

 

* Adjusted PBT = Profit before tax, depreciation, impairment, other operating income and exceptional adjustments.

 

 

 

Condensed consolidated interim balance sheet

 

 

 

 

 

 

 

 

Unaudited

Unaudited

Audited

 

 

31 October

31 October

30 April

 

 

2016

2015

2016

 

 

£000

£000

£000

Non-current assets

 

 

 

 

Property, plant and equipment

 

106

155

129

Investments in joint ventures

 

764

2,087

785

Deferred tax asset

 

1,400

1,400

1,400

Other receivables

 

760

827

760

 

 

3,030

4,469

3,074

Current assets

 

 

 

 

Work in progress

 

2,807

2,807

2,807

Trade and other receivables

 

6,687

5,129

5,616

Cash and cash equivalents

 

-

514

23

 

 

9,494

8,450

8,446

Total assets

 

12,524

12,919

11,520

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

(5,303)

(5,887)

(5,450)

Bank borrowings and overdrafts

 

(1,962)

(1,537)

(1,483)

Provisions

 

(56)

(31)

(56)

 

 

(7,321)

(7,455)

(6,989)

Net current assets

 

2,173

995

1,457

 

Non current liabilities

 

 

 

 

Amounts falling due after more than one year

 

(433)

(1,560)

(527)

Long term provisions

 

(128)

(109)

(171)

Total liabilities

 

(7,882)

(9,124)

(7,687)

 

 

 

 

 

Net assets

 

4,642

3,795

3,833

 

 

 

 

 

Equity

 

 

 

 

Share capital

 

590

583

588

Share premium

 

59

-

43

Share-based payments reserve

 

21

29

10

Special reserve

 

3,248

3,491

3,248

Retained earnings

 

724

(308)

(56)

Total equity

 

4,642

3,795

3,833

Condensed consolidated interim statement of changes in equity

 

 

 

 

 

 

 

 

 

Share

Share

Share-based

Special

Retained

Total

 

capital

Premium

payment reserve

reserve

earnings

equity

 

£000

£'000

£000

£000

£000

£000

Balance at 1 May 2016

588

43

10

3,248

(56)

3,833

 

 

Total comprehensive income for the year

-

-

-

-

780

780

 

 

Issue of shares to Ashley House Share Incentive Plan

2

16

-

-

-

18

 

Share-based payments charge

-

-

11

-

-

11

 

 

Balance at 31 October 2016

590

59

21

3,248

724

4,642

 

 

 

 

 

 

 

Balance at 1 May 2015

583

-

22

3,491

(546)

3,550

 

 

 

 

Total comprehensive income for the year

-

-

-

-

238

238

 

 

 

 

Share-based payments charge

-

-

7

-

-

7

 

 

 

 

Balance at 31 October 2015

583

-

29

3,491

(308)

3,795

 

 

 

 

 

 

 

Balance at 1 May 2015

583

-

22

3,491

(546)

3,550

 

 

 

 

Total comprehensive income for the year

-

-

-

(243)

490

247

 

 

 

 

Issue of shares to Ashley House Share Incentive Plan

5

43

-

-

-

48

 

 

 

 

Cancellation of previous share option scheme

-

-

(22)

-

-

(22)

 

 

 

 

New share option scheme charge

-

-

10

-

-

10

 

 

 

 

At 30 April 2016

588

43

10

3,248

(56)

3,833

 

 

 

Condensed interim cash flow statement

 

 

Unaudited

Unaudited

Audited

 

6 months to

6 months to

Year to

 

31 October

31 October

30 April

 

2016

2015

2016

 

£000

£000

£000

Operating activities

 

 

 

Profit before taxation

780

238

241

Adjustments for:

 

 

 

Share-based payments charge/(credit)

11

7

(12)

Depreciation and impairment

55

185

1,514

Share of results of joint ventures

(165)

42

(97)

Dividends received from joint ventures

159

34

174

Acquisition of investment in joint ventures and associates

-

(17)

-

Interest received

-

-

(1)

Interest paid

401

234

491

Operating cash flows before movements in working capital

1,241

723

2,310

 

 

 

 

Decrease in work in progress

-

1,489

1,489

Increase in trade and other receivables

(1,071)

(2,094)

(2,514)

Decrease in trade and other payables

(147)

(368)

(805)

(Decrease)/increase in provision

(43)

(8)

79

Cash (used by)/from operations

(20)

(258)

559

 

 

 

 

Income tax paid

-

-

6

Interest receivable

-

-

1

Interest paid

(401)

(234)

(491)

Net cash (used by)/generated from operating activities

(421)

(492)

75

 

 

 

 

Investing activities

 

 

 

Purchase of shares in joint venture

-

-

(17)

Purchase of property, plant and equipment

(5)

(64)

(66)

Net cash used by investing activities

(5)

(64)

(83)

 

 

 

 

Financing activities

 

 

 

Issue of ordinary shares

18

-

48

Proceeds from borrowings

-

300

600

Repayment of borrowings

(90)

(86)

(1,473)

Net cash generated (used by)/generated from financing activities

(72)

214

(825)

 

 

 

 

Net decrease in cash and cash equivalents

(498)

(342)

(833)

 

 

 

 

Cash and cash equivalents at beginning of period

23

856

856

 

 

 

 

Cash and cash equivalents at end of period

(475)

514

23

 

 

 

 

Notes to the condensed consolidated interim financial statements

 

 

1 Nature of operations

The principal activity of the Group is the supply of design, construction management and consultancy, primarily working with providers of healthcare and social care on infrastructure developments from project inception to completion of construction and beyond.

Ashley House's condensed consolidated interim financial statements (the interim financial statements) are presented in pounds sterling (£), which is also the functional currency of the parent company. These interim financial statements were approved for issue by the Board of directors on 25 January 2017.

The financial information set out in these interim financial statements does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 30 April 2016 have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under Section 498(2) of the Companies Act 2006.

 

2 Basis of preparation

These interim financial statements are for the six months ended 31 October 2016. They have been prepared following the recognition and measurement principles of IFRS. They do not include all of the information required for full annual financial statement and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 April 2016.

These interim financial statements have been prepared on the going concern basis, under the historical cost convention, except for the revaluation of certain financial instruments which are carried at fair value.

These interim financial statements have been prepared in accordance with the accounting policies adopted in the last annual financial statements for the year to 30 April 2016.

 

3 Earnings per share

The calculation of the basic earnings per share is based on the profit attributable to ordinary shareholders divided by the weighted average number of shares in issue during the period.

 

 

 

Weighted

 

 

Adjusted

 

average

Per share

 

PBT*

Profit

number

amount

6 months to 31 October 2016

£000

£000

of shares

Pence

Basic and diluted earnings per share

780

58,932,721

1.32p

Profit per share based on Adjusted PBT*

180

58,932,721

0.31p

 

 

 

 

Weighted

 

 

Adjusted

 

average

Per share

 

PBT*

Profit

number

amount

6 months to 31 October 2015

£000

£000

of shares

Pence

Basic and diluted earnings per share

238

58,319,755

0.41p

Profit per share based on Adjusted PBT*

409

58,319,755

0.70p

 

 

 

 

Weighted

 

 

Adjusted

 

average

Per share

 

PBT*

Profit

number

amount

Year to 30 April 2016

£000

£000

of shares

Pence

Basic and diluted profit per share

 

247

58,355,706

0.42p

Profit per share based on Adjusted PBT*

1,160

 

58,355,706

1.99p

 

* Adjusted PBT = Profit before taxation, depreciation, impairment other operating income.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DELFLDFFLBBV
Date   Source Headline
11th Dec 20205:30 pmRNSAshley House
11th Dec 20207:00 amRNSReverse Takeover Update and Administration
26th Aug 20201:27 pmRNSProposed Company Voluntary Arrangement
24th Aug 20207:00 amRNSProposed CVA – second adjournment of meeting
18th Aug 20201:05 pmRNSProposed CVA – adjournment of meeting
30th Jul 202012:25 pmRNSProposed CVA and potential Reverse Takeover
7th May 20205:25 pmRNSSale of Interests in PHL and LIFT
30th Mar 20201:59 pmRNSAdministration of F1 Modular and General Update
6th Mar 20207:30 amRNSSuspension - Ashley House Plc
6th Mar 20207:00 amRNSFinancial Update & Suspension of Trading
2nd Mar 202011:53 amRNSHolding(s) in Company
27th Feb 20207:00 amRNSTrading update & Withdrawal from NEX
31st Jan 20207:00 amRNSTrading Update
30th Jan 20201:45 pmRNSHolding(s) in Company
11th Dec 201911:01 amRNSAppointment of Non-executive director
10th Dec 201911:29 amRNSResult of Annual General Meeting
10th Dec 20197:00 amRNSAnnual General Meeting and Trading update
14th Nov 20197:00 amRNSYear End Change, Trading Update and Interim Report
7th Nov 20195:04 pmRNSDirectors' & PDMRs' Dealings
1st Nov 201910:10 amRNSHolding(s) in Company
30th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20192:23 pmRNSHolding(s) in Company
23rd Oct 20194:29 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSale of Interest in Morgan Ashley
2nd Sep 20197:00 amRNSTrading Update
6th Aug 20197:00 amRNSDirectorate Change
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
1st Aug 20197:00 amRNSTrading Update
5th Jul 20197:00 amRNSTrading Update
28th Jun 201911:51 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
9th May 201910:19 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSSchemes Update
3rd May 20191:21 pmRNSDirector/PDMR Shareholding
18th Feb 201912:56 pmRNSHolding(s) in Company
15th Feb 20192:53 pmRNSHolding(s) in Company
15th Feb 20192:50 pmRNSHolding(s) in Company
14th Feb 20194:41 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
1st Feb 20191:38 pmRNSDirectors' & PDMRs' Dealings
31st Jan 20197:00 amRNSInterim Report
28th Jan 20199:40 amRNSAdditional Directorships - Andrew Willetts
16th Jan 201912:50 pmRNSChange of Accounting Year End
1st Nov 20187:00 amRNSDirectors' & PDMRs' Dealings
12th Sep 20181:08 pmRNSResult of AGM
16th Aug 20187:00 amRNSPreliminary Results
9th Aug 20187:00 amRNSJohn Moy
1st Aug 201811:34 amRNSDirectors' & PDMRs' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.